Filament Health Corp. (OTCQB: FLHLF) (Cboe CA: FH) (FSE: 7QS) ("Filament" or the "Company"), a clinical‐stage natural psychedelic drug development company, today announced that it has shipped its ...

Detailed price information for Nextleaf Solutions Ltd (OILS-CN) from The Globe and Mail including charting and trades.

Philip Morris Intl. expands into cannabis via Avicanna partnership, focusing on medical research and innovation: How this ...

In recent years, there has been a significant rise in the interest and acceptance of psilocybin mushrooms across Canada.

Detailed price information for Advisorshares Psychedelics ETF (PSIL-A) from The Globe and Mail including charting and trades.

As awareness of the potential benefits of psilocybin mushrooms grows, more Canadians are seeking safe and reliable ways to ...

Cybin (NYSE American: CYBN) (NEO: CYBN) , a neuropsychiatry platform company, announced its first strategic partnership agreement (“SPA”) with Segal Trials as part of its multinational pivotal Phase 3 ...

MDMA, and ketamine, is gaining recognition as a groundbreaking approach to treating mental health conditions, including PTSD, ...

First Participants Dosed: Optimi's natural psilocybin extract was administered to participants at Rangiwaho Marae, marking a historic step in combining traditional healing frameworks with modern ...

Psychedelics are poised to revolutionize wellness by offering new approaches to mental health, personal growth, and spiritual ...

A paramedic has shared details of his near-death experience after being electrocuted. After the experience he revealed that ...

NDAQ:CMND) Clearmind Medicine Announces the Publication of European Patent Application for Binge Behavior Psychedelic Combination Treatment ...